Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes

International Journal of Cancer

Volumn 81, Issue 4, 1999, Pages 573-579

  Ferrarini, Marina ^a   Imro, Maria Adele ^a   Sciorati, Clara ^a   Heltai, Silvia ^a   Protti, Maria Pia ^a   Pellicciari, Carlo ^b   Rovere, Patrizia ^a   Manfredi, Angelo A ^a   Rugarli, Claudio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; FAS ANTIGEN; FAS LIGAND;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; CYTOTOXICITY TEST; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; CELLS, CULTURED; CLONE CELLS; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MELANOMA; MEMBRANE GLYCOPROTEINS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032929939     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990517)81:4<573::AID-IJC12>3.0.CO;2-W     Document Type: Article

References (21)

1. ALDERSON, M.R., TOUGH, T.W., DAVIS-SMITH, T., BRADDY, S., FALK, B., SCHOOLEY, K.A., GOODWIN, R.G., SMITH, C.A., RAMSDELL, F. and LYNCH, D.H., Fas ligand mediates activation-induced cell death in human T lymphocytes. J. exp. Med., 181, 71-77 (1995).
2. ANDRADE, F., ROY, S., NICHOLSON, D., THORNBERRY, N., ROSEN, A. and CASCIOLA-ROSEN, L., Granzyme B directly and efficiently cleaves several downstream caspase substrates-implications for CTL-induced apoptosis. Immunity, 8, 451-460 (1998).
3. ATKINSON, E.A. and BLEACKLEY, R.C., Mechanisms of lysis by cytotoxic T cells. Crit. Rev. Immunol., 15, 359-384 (1995).
4. BUECHNER, S.A., WERNLI, M., HARR, T., HAHN, S., ITIN, P. and ERB, P., Regression of basal-cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95(Apo-1/Fas)-CD95-ligand-induced suicide. J. clin. Invest., 100, 2691-2696 (1997).
5. CIFONE, M.G., DE MARIA, R., RONCAIOLI, P., RIPPO, M.R., AZUMA, M., LANIER, L.L., SANTONI, A. and TESTI, R., Apoptotic signalling through CD95 (Fas/Apol) activates an acidic sphingomyelinase. J. exp. Med., 177, 1547-1552 (1993).
6. ENARI, M., TALANIAN, R.V., WONG, W.W. and NAGATA, S., Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (Lond.), 380, 723-726 (1996).
7. FERRARINI, M., HELTAI, S., TONINELLI, E., SABBADINI, M.G., PELLICCIARI, C. and MANFREDI, A.A., Daudi lymphoma killing triggers the programmed death of cytotoxic V-γ9/Vδ2 T lymphocytes. J. Immunol., 154, 3704-3712 (1995).
8. FROELICH, J.C., DIXIT, V.M. and YANG, X., Lymphocyte-granule-mediated apoptosis: matters of viral mimicry and deadly proteases. Immunol. Today, 19, 30-36 (1998).
9. GENESTRIER, L., PRIGENT, A.-F., PAILLOT, R., QUEMENEUR, L., DURAND, I., BANCHEREU, J., REVILLARD, J.P. and BONNEFOY-BERARD, N., Caspase-dependent ceramide production in Fas-and HLA-Class-I-mediated peripheral-T-cell apoptosis. J. biol. Chem., 273, 5060-5066 (1998).
10. GRIFFITH, T.S. and FERGUSON, T.A., The role of FasL-induced apoptosis in immune privilege. Immunol. Today, 18, 240-244 (1997).
11. HAHNE, M., RIMOLDI, D., SCHROTER, M., ROMERO, P., SCHREIER, M., FRENCH, L.E., SCHNEIDER, P., BORNAND, T., FONTANA, A., LIENARD, D., CEROTTINI, J.-C. and TSCHOPP, J., Melanoma-cell expression of Fas(Apo-1/ CD95) ligand: implications for tumor immune escape. Science, 274, 1363-1366 (1996).
12. IRMLER, M. and 12 OTHERS, Inhibition of death receptor signals by cellular FLIP. Nature (Lond), 388, 190-195 (1997).
13. KAGI, D., LEDERMANN, B., BURKI, K., ZINKERNAGEL, R.M. and HENGARTNER, H., Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Ann. Rev. Immunol., 14, 207-232 (1996).
14. MANFREDI, A.A., HELTAI, S., ROVERE, P., SCIORATI, C., GALATI, G., RUGARLI, C., VAIANI, R., CLEMENTI, E. and FERRARINI, M., Mycobacterium tuberculosis exploits the CD95/CD95 ligand system of γδ T cells to cause apoptosis. Europ. J. Immunol., 28, 1798-1806 (1998).
15. MARTIN, S.J., REUTELINGSPERGER, C.P.M., MCGAHON, A.J., RADER, J.A., VAN SCHIE, R.C.A.A., LAFACE, D.M. and GREEN, D.R., Early redistribution of plasma-membrane phosphatidylserine is a general feature of apoptosis regardless of the inhibition by over-expression of Bcl-2 and Abl. J. exp. Med., 182, 1545-1556 (1995).
16. NAGATA, S., Apoptosis by death factor. Cell, 88, 355-365 (1997).
17. + CTL clones resist Fas-ligand-induced apoptosis and use Fas/Fas-ligand-independent mechanisms for tumor killing. J. Immunol., 161, 1220-1230 (1998).
18. SCIORATI, C., ROVERE, P., FERRARINI, M., HELTAI, S., MANFREDI, A.A. and CLEMENTI, E., Autocrine nitric oxide modulates CD95-induced apoptosis in γδ T lymphocytes. J. biol. Chem., 272, 23211-23215 (1997).
19. SEINO, K.-I., KAYAGAKI, N., OKUMURA, K. and YAGITA, H., Anti-tumor effect of locally produced CD95 ligand. Nature Med., 3, 165-170 (1997).
20. SHU, H.-B., HALPIN, D.R. and GOEDDEL, D.V., Casper is a FADD-and caspase-related inducer of apoptosis. Immunity, 6, 751-763 (1997).
21. WALKER, P.R., SAAS, P. and DIETRICH, P.Y., Role of Fas ligand (CD95L) in immune escape. The tumor cell strikes back. J. Immunol., 158, 4521-4524 (1997).